Beijing Tiantan Biological Products Corp Ltd

SHG:600161 China Biotechnology
Market Cap
$4.32 Billion
CN¥31.72 Billion CNY
Market Cap Rank
#4923 Global
#571 in China
Share Price
CN¥16.04
Change (1 day)
-0.43%
52-Week Range
CN¥15.58 - CN¥23.17
All Time High
CN¥74.24
About

Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationlly. Its products include human albumin; intravenous human immunoglobulin; rabies patient immunoglobulin; tetanus human immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamin… Read more

Beijing Tiantan Biological Products Corp Ltd - Asset Resilience Ratio

Latest as of June 2024: 8.08%

Beijing Tiantan Biological Products Corp Ltd (600161) has an Asset Resilience Ratio of 8.08% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥1.22 Billion
Cash + Short-term Investments
Total Assets
CN¥15.14 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Beijing Tiantan Biological Products Corp Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Beijing Tiantan Biological Products Corp Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.22 Billion 8.08%
Total Liquid Assets CN¥1.22 Billion 8.08%

Asset Resilience Insights

  • Limited Liquidity: Beijing Tiantan Biological Products Corp Ltd maintains only 8.08% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Beijing Tiantan Biological Products Corp Ltd Industry Peers by Asset Resilience Ratio

Compare Beijing Tiantan Biological Products Corp Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980
Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007
Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
Biotechnology 4.35%

Annual Asset Resilience Ratio for Beijing Tiantan Biological Products Corp Ltd (None–None)

The table below shows the annual Asset Resilience Ratio data for Beijing Tiantan Biological Products Corp Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
No yearly data available.
pp = percentage points